UNIVARIATE ANALYSIS | Cancer specific survival | ||
---|---|---|---|
HR | 95% CI | p-value | |
Primary pathological tumour stage (pT, 2002) | |||
pT1a ref. | |||
pT1b | 5.5 | 0,7 – 42.7 | 0.102 |
pT2 | 11.5 | 1,5 – 87.6 | 0.018 |
pT3a | 16.3 | 2.2 – 123.5 | 0.007 |
pT3b | 21.5 | 2.9 – 157.1 | 0.003 |
pT4 | 63.5 | 8.1 – 498.2 | <0.001 |
Gender male ref. | 0.74 | 0.48 – 1.14 | 0.170 |
Age (continuous), per 5 years | 1.01 | 0.91 – 1.11 | 0.908 |
Continuously coded tumour size (CCTS), per 10 cm | 2.98 | 1.87 – 4.75 | <0.001 |
Mode of detection (Incidental vs. Symptomatic) | 3.89 | 1.58 – 9.59 | 0.003 |
ECOG PS (≥ 1 vs. 0) | 1.94 | 1.26 – 2.98 | 0.002 |
ESR (≥ 28 mm vs. < 28 mm) | 3.36 | 2.11 – 5.35 | <0.001 |
LNI (pN 1/2 vs. pN x/0) | 5.38 | 3.17 – 9.10 | <0.001 |
SDM (M + vs. M 0) | 6.56 | 4.17 – 10.33 | <0.001 |
VI (pV 1/2 vs. pV 0) | 2.33 | 1.51 – 3.60 | <0. 001 |